NEW YORK, July 31 – Sequenom said Tuesday its second-quarter revenues more than tripled to $7.4 million, compared with $1.9 million in the year ago period, as the San Diego-based company sold an increased number of its MassArray genotyping systems and signed several service deals.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.